ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
15 hedge funds and large institutions have $21M invested in Anebulo Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.78% less ownership
Funds ownership: 29.96% → 28.18% (-1.8%)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$65K | |
| 2 | +$58.6K | |
| 3 | +$1.21K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$371 |
| 5 |
JP Morgan Chase
New York
|
+$23 |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$36.3K | |
| 3 | -$10.2K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.94K |
| 5 |
LA
LVW Advisors
Pittsford,
New York
|
-$2.57K |